Clinical Trial Update: Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liraglutide for beta-cell function in C-peptide positive Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Per-Ola Carlsson | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED